PRINCIPAL FINANCIAL GROUP INC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$11,062,970
-26.0%
411,722
-1.8%
0.01%
-20.0%
Q2 2023$14,943,750
+32.5%
419,062
-5.6%
0.01%
+25.0%
Q1 2023$11,278,032
-35.8%
444,017
+2.6%
0.01%
-38.5%
Q4 2022$17,560,737
+24.1%
432,957
+1.1%
0.01%
+18.2%
Q3 2022$14,153,000
-7.2%
428,218
-1.2%
0.01%0.0%
Q2 2022$15,259,000
-12.5%
433,385
+14.3%
0.01%0.0%
Q1 2022$17,434,000
-38.5%
379,075
-11.4%
0.01%
-35.3%
Q4 2021$28,371,000
+2.6%
427,908
-3.4%
0.02%
-5.6%
Q3 2021$27,645,000
-35.5%
442,815
-14.4%
0.02%
-35.7%
Q2 2021$42,832,000
+24.7%
517,167
-0.1%
0.03%
+16.7%
Q1 2021$34,337,000
+29.8%
517,820
+50.2%
0.02%
+20.0%
Q4 2020$26,452,000
+85.2%
344,738
+3.9%
0.02%
+66.7%
Q3 2020$14,286,000
-3.3%
331,790
-3.0%
0.01%
-7.7%
Q2 2020$14,767,000
+34.1%
341,918
-10.7%
0.01%
+8.3%
Q1 2020$11,015,000
-65.9%
382,870
-24.9%
0.01%
-55.6%
Q4 2019$32,329,000
+39.2%
509,670
-38.2%
0.03%
+35.0%
Q3 2019$23,223,000
+6.1%
824,095
-0.2%
0.02%0.0%
Q2 2019$21,878,000
+1991.6%
825,583
+1348.3%
0.02%
+1900.0%
Q1 2019$1,046,000
+50.7%
57,005
+2.0%
0.00%0.0%
Q4 2018$694,000
-40.3%
55,911
-7.9%
0.00%0.0%
Q3 2018$1,163,000
+52.8%
60,680
+8.5%
0.00%0.0%
Q2 2018$761,000
+3208.7%
55,933
+355.5%
0.00%
Q1 2017$23,000
+43.8%
12,280
+15.5%
0.00%
Q4 2016$16,000
-79.5%
10,6310.0%0.00%
Q3 2016$78,000
+36.8%
10,6310.0%0.00%
Q2 2016$57,00010,6310.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders